Heyman Richard A. 内部人交易：近期 SEC Form 4 交易

Name: Heyman Richard A. Insider Trading -- SEC Form 4 Transactions
Creator: ko.io

过去 18 个月，Heyman Richard A.（CIK 1584759）在 2 家公司共报告 17 笔 SEC Form 4 内部人交易（最近一笔 2026-10-02）。

日期	公司	身份	类型	股数	市值
2026-10-02	Oric Pharmaceuticals, Inc. (ORIC)	董事	买入	3,500	$5,600
2026-10-02	Oric Pharmaceuticals, Inc. (ORIC)	董事	卖出	3,500	$45,199
2026-10-02	Oric Pharmaceuticals, Inc. (ORIC)	董事	卖出	3,200	$41,325
2026-07-28	Oric Pharmaceuticals, Inc. (ORIC)	董事	买入	3,500	$5,600
2026-07-28	Oric Pharmaceuticals, Inc. (ORIC)	董事	卖出	7,000	$84,140
2026-07-28	Oric Pharmaceuticals, Inc. (ORIC)	董事	卖出	6,100	$73,322
2026-07-08	Oric Pharmaceuticals, Inc. (ORIC)	董事	卖出	300	$3,600
2026-02-19	Enliven Therapeutics, Inc. (ELVN)	董事	卖出	1,230	$32,201
2026-01-22	Enliven Therapeutics, Inc. (ELVN)	董事	卖出	512	$13,548
2026-01-22	Enliven Therapeutics, Inc. (ELVN)	董事	卖出	718	$19,357
2026-01-20	Oric Pharmaceuticals, Inc. (ORIC)	董事	卖出	3,500	$42,000
2026-01-20	Oric Pharmaceuticals, Inc. (ORIC)	董事	卖出	3,200	$38,400
2026-01-12	Enliven Therapeutics, Inc. (ELVN)	董事	卖出	1,620	$40,500
2026-01-12	Enliven Therapeutics, Inc. (ELVN)	董事	卖出	8,015	$200,696
2026-01-12	Enliven Therapeutics, Inc. (ELVN)	董事	卖出	4,285	$107,125
2025-10-03	Oric Pharmaceuticals, Inc. (ORIC)	董事	买入	31,353	$50,165
2025-10-03	Oric Pharmaceuticals, Inc. (ORIC)	董事	买入	1,447	$5,426

来源：SEC Form 4 申报文件 · 截至 2026-10-02